Recruiting studies: Ceftazidime Avibactam

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07327619 EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Phase 4 · 4 location(s) · National University of Singapore · NCT05979545 Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB
Phase 4 · 1 location(s) · Jing Zhou · NCT07478484 PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-trea
Phase N/A · 11 location(s) · University of Bologna · NCT06651047 A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea
Phase N/A · 1 location(s) · Pfizer · NCT05733104 PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE
Phase N/A · 2 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06717594

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.